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not folate, is physiological, facilitating
avoidance of host-parasite competition.
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Folatemetabolism is essential for DNA synthesis and
a validated drug target in fast-growing cell popula-
tions, including tumors and malaria parasites.
Genome data suggest that Plasmodium has retained
its capacity to generate folates de novo. However,
the metabolic plasticity of folate uptake and biosyn-
thesis by the malaria parasite remains unresolved.
Here, we demonstrate that Plasmodium uses an
aminodeoxychorismate synthase and an amino-
deoxychorismate lyase to promote the biogenesis
of the central folate precursor para-aminobenzoate
(pABA) in the cytoplasm. We show that the parasite
depends on de novo folate synthesis only when die-
tary intake of pABA by the mammalian host is
restricted and that only pABA, rather than fully
formed folate, is taken up efficiently. This adaptation,
which readily adjusts infection to highly variable
pABA levels in the mammalian diet, is specific to
blood stages and may have evolved to avoid folate
competition between the parasite and its host.INTRODUCTION
Malaria parasites replicate at high rates in themammalian blood-
stream. Consequently, they require large quantities of folate
and folate precursors, which they scavenge from the serum or
synthesize de novo (Krungkrai et al., 1989; M€uller and Hyde,
2013). In contrast, the mammalian host strictly depends on the
dietary uptake of preformed folates. Folates promote essential
functions during one-carbon transfer reactions and consist of
three major moieties: para-aminobenzoate (pABA), pterin, and
glutamate. The growth-inhibitory effects of antifolates targeting
the enzymes dihydropteroate synthase (DHPS) and dihydrofo-
late reductase-thymidylate synthase (DHFR-TS) have been ex-
ploited for antimalarial therapy (Nzila, 2006). Due to the emer-
gence of antifolate resistance, these enzymes have received356 Cell Reports 26, 356–363, January 8, 2019 ª 2018 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://considerable attention (Gregson and Plowe, 2005; Heinberg
and Kirkman, 2015). For therapeutic approaches, however, the
enzymes promoting biogenesis of the central folate precursor
pABA have been neglected.
It is believed that chorismate, which is produced via the
shikimate pathway (Roberts et al., 1998), is converted to
pABA in a two-step reaction (Figure 1A). A potential amino-
deoxychorismate synthase (ADCS, PBANKA_0823300) and an
aminodeoxychorismate lyase (ADCL, PBANKA_1322100) are
predicted by Plasmodium genome sequences (Magnani et al.,
2013; Salcedo-Sora and Ward, 2013; Triglia and Cowman,
1999). However, their roles in Plasmodium folate metabolism
during infection remain unexplored.
Here, we investigate the function of ADCS and ADCL in folate
biogenesis. Using a combination of reverse genetics and defined
host nutrition, we provide evidence for two complementary path-
ways: de novo biosynthesis and scavenging of pABA. Faculta-
tive auxotrophy of pABA during blood infection thus exemplifies
the metabolic flexibility of the malaria parasite in vivo.
RESULTS AND DISCUSSION
Experimental Genetics of the pABA Synthesis Pathway
We initiated our analysis by assessing ADCS and ADCL expres-
sion throughout the parasite life cycle, using the murine malaria
model parasite P. berghei. Transgenic parasite lines expressing
the endogenous genes fused tomCherry-3xMycwere generated
(Figures S1A and S1B) and analyzed by live fluorescence micro-
scopy. Co-localization with a cytosolic GFPmarker revealed that
both enzymes localize to the parasite cytoplasm (Figure 1B).
ADCS expression was restricted to blood stage trophozoites
and liver stages, but remained below the detection limit in rings,
in schizonts, and throughout mosquito infection. This finding in-
dicates distinct roles for ADCS in the mammalian host only. In
contrast,ADCLwas ubiquitously expressed during life cycle pro-
gression (Figure 1B).
We next assessed the importance of both enzymes by tar-
geted gene disruption and were successful in generating mu-
tants lacking either ADCS or ADCL, as indicated by diagnostic
PCR and Southern blot analysis (Figures 1C, S1C, and S1D)..
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Experimental Genetics of the Plasmodium pABA Biosynthesis Pathway
(A) pABA biosynthesis by the malaria parasite. Conversion of chorismate into aminodeoxychorismate (ADC) is catalyzed by ADC synthase (ADCS). ADC is
converted into para-aminobenzoate (pABA) by ADC lyase (ADCL).
(B) ADCS and ADCL are cytoplasmic proteins. Transgenic P. berghei parasites expressing mCherry-3xMyc-tagged ADCS or ADCL and a cytoplasmic GFP
marker (Kooij et al., 2012) were passed through the life cycle and imaged live during asexual blood stages, gametogenesis (exflagellatingmale, egressed female in
inset), the mosquito oocyst stage, and the liver stage of infection. Shown are the signals of the tagged proteins (red, left), the cytoplasmic GFP marker (green,
center left), a merge of both signals (center right), and amerge of differential interference contrast images (DIC) with Hoechst 33342 nuclear dye (DNA, blue, right).
The DNA of male gametocytes was not stained due to interference of the dye with exflagellation. Bars, 5 mm.
(C) Targeted gene deletion of ADCS and ADCL. Diagnostic PCRs of the WT locus (left) and of the drug-selected and isolated parasites (right) using primer
combinations indicated in Figure S1C and Table S1. Green frames indicate successful gene deletion.
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Figure 2. Dietary pABA Restriction Affects Plasmodium Parasites Only in the Absence of ADCS or ADCL
(A) Normal blood stage growth of adcs parasites in vivo using a conventional rodent diet. Shown is an intravital competition assay. Equal numbers of mCherry-
fluorescent BerredWT andGFP-fluorescent adcs blood stage parasites were co-injected, and peripheral blood was analyzed daily by flow cytometry. n.s., non-
significant; analysis of covariance (ANCOVA); n = 4.
(B) Concentrations of pABA and 5-MTHF in conventional rodent diet andmilk-based diet. n.d., not detected. **p < 0.01; Student’s t test; n = 3. See also Figure S2.
(C and D) Blood stage propagation ofWT and adcs parasites was analyzed with an intravital competition assay using amilk-basedmouse diet in the absence (C)
or presence (D) of dietary pABA. ***p < 0.001; *p < 0.05; ANCOVA; n = 7 (C) or n = 3 (D). Note that the statistical outcome in (D) is due to low variance. See also
Figures S1 and S3.
(E) Blood stage development of WT parasites in milk-fed mice in the absence or presence of pABA. n.s., non-significant; ANCOVA; n = 3.
(F) ADCL-deficient parasites are also sensitive to dietary pABA restriction. Shown is adcl growth in mice receiving normal or milk-based diet with or without
pABA supplementation. **p < 0.001; n.s., non-significant; ANCOVA; n = 5.
(G) Dietary pABA restriction results in declining adcs parasitemia. On day 18, pABA was re-supplied (arrow). WT-infected animals had to be sacrificed due to
hyperparasitemia. n = 3 (WT) and 6 (adcs). In each panel, mean values ± SDs are shown.
(H) Latent adcs infection and lack of parasite clearance during continued pABA restriction. Shown are 82 days of adcs infection in milk-fed mice. Gray squares,
negative; blue squares, positive in Giemsa-stained blood films. On day 65, pABA was re-supplied (arrow). Note the repeated re-emergence of patent blood
infection. y, death; n = 10.
(I) Latent adcs infection elicits anti-plasmodial antibodies. BerredWTmerozoites (red) were stained with mouse serum and fluorescently labeled secondary anti-
mouse immunoglobulin G (IgG) antibodies (green). Sera were derived from naive mice, mice with acute P. berghei WT infections (5 days), and from long-term
adcs-infected mice (H). Bar, 5 mm.Plasmodium Blood Stages Depend on Host-Derived
Nutritional pABA Only upon Loss of Endogenous
Synthesis
Blood propagation of adcs parasiteswas compared towild-type
(WT) in mice fed with conventional rodent diet using an intravital
competition assay (Matz et al., 2013). Parasite growth remained
unaltered in the absence of ADCS (Figure 2A), suggestive of effi-
cient salvage of folate or folate precursors, such as pABA. For358 Cell Reports 26, 356–363, January 8, 2019this reason, we restricted pABA levels by providing the host with
a diet based on spray-driedwhole-milk powder. Metabolite quan-
tification by ultra-performance liquid chromatography/Orbitrap-
mass spectrometry (UPLC/Orbitrap-MS) confirmed that pABA is
abundant in conventional mouse feed and absent from milk diet
(Figures 2B and S2B). Moreover, conventional diet is fortified
with high levels of the artificial folate analog folic acid (FA),
which is absent from milk. In contrast to conventional feed, milk
diet contained considerable levels of the naturally occurring
5-methyltetrahydrofolate (5-MTHF; Figures 2B and S2B). In the
liver, pABA is predominantly converted to three derivatives by
either acetylation or glycine conjugation (Figure S2A; Song and
Hsu, 1996). We measured the levels of two pABA metabolites,
para-acetamidobenzoate (pACBA) and para-aminohippurate
(pAHA), in the mouse serum. Although pAHA remained undetect-
able, pACBA levels were high only in mice fed with conventional
diet (Figure S2C).
In milk-fed mice adcs parasite propagation was severely
impaired, whereas WT parasites displayed normal growth (Fig-
ure 2C). This suggests that Plasmodium can compensate for
the absence of dietary pABA by ADCS-dependent de novo
biosynthesis and that parasite propagation is only arrested in
the combined absence of pABA salvage and endogenous syn-
thesis. This phenotype was recapitulated by an independent
adcs parasite line lacking the drug-selectable cassette, thus
ruling out interference of the DHFR resistance marker (Figures
S1C and S1E–S1G). Upon pABA supplementation via the drink-
ing water, adcs growth was fully restored, andmutant parasites
grew indistinguishable from WT in milk-fed mice (Figure 2D).
Moreover, blood propagation of WT parasites was largely inde-
pendent of dietary pABA, which is indicative of sufficient rates
of de novo pABA synthesis (Figure 2E). Our findings are
congruent with previous observations that pABA antagonizes
the efficacy of antifolate drugs, including sulfadoxine, a struc-
tural pABA analog and competitive inhibitor of DHPS (Milhous
et al., 1985; Watkins et al., 1985).
We also compared blood infection of transgenic parasites
lacking the second pABA synthesis enzyme, ADCL, in mice
receiving different diets. adcl parasites also depend on nutri-
tional pABA, demonstrating that both enzymes, ADCS and
ADCL, promote pABA biogenesis during blood infection (Fig-
ure 2F). The ubiquitous expression of ADCL suggests additional
functions, especially during mosquito stages (Figure 1B). A
previous study demonstrated a substantial secondary amino-
transferase activity of Plasmodium falciparum ADCL, which
was suggested as contributing to the detoxification of exoge-
nous D-amino acids (Magnani et al., 2013).
We also quantified tagged ADCS by live fluorescence micro-
scopy to test for a potential regulation of expression in the
absence of pABA (Figure S3). We demonstrated that steady-
state levels of ADCS remain constant irrespective of dietary
pABA availability.
Continued pABA restriction led to the retraction of adcs
parasitemia from day 12 onward, which was immediately re-
verted upon addition of pABA on day 18 (Figure 2G). During
more extended periods of pABA deficiency, adcs parasitemia
dropped below the detection threshold, followed by alter-
nating periods of re-emergence and retraction, indicative of
latent malaria infection (Figure 2H). We propose that adcs
survival is due to the inefficient utilization of alternate folate
sources or to parasite hibernation, as described previously
for P. falciparum under amino acid-depleted conditions (Bab-
bitt et al., 2012). Upon pABA resupply 2 months later, adcs
parasites continued their cycles of emergence and retraction,
which is indicative of parasite tolerance rather than sterile pro-
tection (Figure 2H).The persistence of latent infection precludes the combined
use of ADCS or ADCL targeting and pABA-free diet as a viable
pharmacological strategy or for experimental blood stage immu-
nizations. Our observations also warrant a cautionary note for
the development of attenuated blood stage vaccine strains.
Although the murine immune systemwas exposed to large para-
site quantities for >80 days, and despite eliciting robust anti-
parasitic antibodies (Figure 2I), infection with adcs parasites
was not resolved, indicating no sterile protection against asexual
P. berghei blood stages.
Metabolite Profiling Identifies pABA Dependency
of Plasmodium Blood Stages
pABA supplementation correlated with elevated pACBA levels
in the serum, which is indicative of efficient ingestion, resorption,
and bioconversion of pABA by the animals (Figures S2C and
S2D). Phenotypic rescue of adcs parasites in milk-fed animals
was also observed upon supplementation with 5-MTHF (Fig-
ure 3A). However, 5-MTHF was rapidly degraded to glutamated
pABA (para-aminobenzoylglutamate [pABG]) in the drinking
water, suggesting that restored adcs growth was due to the up-
take of pABA-related degradation products (Figure 3B). Indeed,
5-MTHF supplementation also led to a significant increase in
serum pACBA levels (Figures S2C and S2D). Furthermore, it was
previously demonstrated that P. falciparum can form pteroylpoly-
glutamate from pABG, which is suggestive of efficient uptake and
utilization by the parasite (Krungkrai et al., 1989).
To prevent folate degradation, we used high concentrations of
the stable folate analog FA (Figure 3B). adcs growth was not
rescued by supplementation with 1.3 mg/kg FA (Figure 3C).
Excessive FA concentrations, as found in fortified mouse feed
(10 mg/kg), improved blood stage development to a certain de-
gree, but did not fully restore WT-like growth, indicating highly
inefficient uptake of folate by the parasite (Figure 3D). This finding
is in good agreement with the considerable levels of 5-MTHF
naturally occurring in milk diet, which could not sustain efficient
adcs parasite growth (Figure 2). Supplementation with FA also
led to elevated pACBA levels in the serum (Figures S2C and
S2D), indicative of folate catabolism. Since exogenous FA did
not restore adcs growth, it is clear that pACBA is not an impor-
tant substrate for Plasmodium. Serum pACBA levels must there-
fore be regarded as a proxy for efficient metabolite conversion
in vivo, while the physiological substrate for the parasite remains
to be determined. Our metabolic data indicate that pABA and its
metabolites rather than folate are salvaged from the host.
We show that de novo synthesis and salvage from the serum
are complementary strategies, which can each fully satisfy the
pABA requirements of the parasite, thus indicating challenges
for the therapeutic exploitation of parasite pABA acquisition.
We provide evidence that the uptake of folate, as opposed to
folate precursors, is of negligible importance for parasite devel-
opment in vivo. Inefficient folate salvage by the parasite is a
fundamental prerequisite for the efficacy of antifolate drugs
and provides a possible explanation for the inconsistent reports
about antifolate treatment failure upon food fortification with FA
(Kupka, 2015).
Previous studies report large effects of pABA-free diet on the
growth and survival of different non-human primate and rodentCell Reports 26, 356–363, January 8, 2019 359
Figure 3. Folate Is a Poor Substrate for the
Malaria Parasite during In Vivo Infection
(A and B) Degradation of 5-MTHF in the drinking
water correlates with the phenotypic rescue of
adcs parasites.
(A) Blood stage propagation of WT and adcs par-
asites was analyzed with the intravital competition
assay using milk diet and 5-MTHF-supplemented
drinking water.
(B) Stability of food supplements. Concentrations of
pABA, 5-MTHF, and FA in drinking water or milk diet.
pABG was measured in 5-MTHF-supplemented
drinking water. n = 1.
(C and D) Folate is not the preferred substrate of
Plasmodium parasites in vivo. Blood stage propa-
gation of WT and adcs parasites using milk diet
supplemented with high (1.3 mg/kg; C) or excessive
levels of FA (10 mg/kg; D). Mean values ± SDs are
shown. **p < 0.01; n.s., non-significant; ANCOVA;
n = 3 (A and C) or n = 6 (D).
See also Figure S2.malaria parasites, including P. berghei, suggestive of a hard-
wired metabolic reliance on pABA salvage (Hawking, 1954;
Jacobs, 1964; Kicska et al., 2003; Maegraith et al., 1952;
Nowell, 1970). In marked contrast, our own results show that
WT growth is largely independent of dietary pABA, in good
agreement with our experimental genetics data. Growth atten-
uation was only detected in adcs-infected mice when fed on
milk diet. We note that we validated dietary pABA restriction
by metabolite quantification of the milk diet and the respective
mouse sera (Figures 2B and S2B–S2D). We cannot formally
exclude that differences in pABA dependency may exist be-
tween different Plasmodium species, but the discrepancies be-
tween our own and previous work with the same murine model
parasite P. berghei remain puzzling. It was previously noted that
the WT growth phenotype in the absence of dietary pABA is
rather variable in P. berghei mouse infections and may depend
on the parasite strain (Nowell, 1970). Contrasting phenotypes
could also be attributed to the circumstances of animal hus-
bandry, which are known to influence the composition of the
gut microbiome (Franklin and Ericsson, 2017; Rausch et al.,
2016). The bacterial community of the digestive tract of the
mouse can shape the outcome of malarial infections via a
modulation of the animal’s inflammatory responses (Villarino
et al., 2016). Presumably, previous breeding and rearing condi-
tions differed significantly from today’s standards and may thus
have affected themicrobiota and in consequence themetabolic
homeostasis, immune status, and susceptibility of the host
toward malaria infection.
Based on our data, we propose that the notion of reduced risk
and severity of malaria in breast-fed infants (Brazeau et al., 2016;
Murray et al., 1978) cannot be attributed to a pABA-deficient diet
but to additional factors, such as slower parasite replication in
erythrocytes harboring fetal hemoglobin and the presence of
maternal antibodies.360 Cell Reports 26, 356–363, January 8, 2019Plasmodium Exploits Alternative Folate Acquisition
during Mosquito and Liver Infection
Next, we investigated the contributions of pABA synthesis and
salvage during life cycle progression. WT and adcs parasites
were co-injected into normally fed mice, allowing for efficient
blood stage growth and gametocytogenesis, and were then
transmitted to Anopheles stephensi mosquitoes in competi-
tion. Oocyst and sporozoite numbers remained unaltered in
the absence of ADCS, independent of pABA supplementation
via the mosquito feeding solution (Figures 4A and 4B). We
further restricted the carryover of pABA metabolites during
the blood meal with the use of milk-fed donor mice. This strat-
egy inevitably led to very low adcs oocyst densities, but it
had no effect on growth or sporulation (Figures 4C–4E), sug-
gesting that other folate-related metabolites from the blood
meal promote mosquito stage development. Our findings are
in perfect agreement with a previous study showing that
P. falciparum oocyst infection rates and densities are indepen-
dent of pABA supplementation in A. stephensi and A. gambiae
(Beier et al., 1994). An attractive hypothesis is that folate re-
quirements may be less stringent during the slow replication
in the mosquito vector, as opposed to rapid proliferation in
the mammalian host.
Next, we inoculated hepatocytes with WT and adcs sporozo-
ites and assessed liver stage development in vitro. Cells were
grown in pABA-free medium containing dialyzed fetal bovine
serum and FA for hepatocyte survival. Parasite morphology,
size, and quantity remained unaltered in the absence of ADCS
and did not improve upon pABA supplementation (Figures 4F
and S4).We then assessed intrahepatic growth in vivoby injecting
sporozoites into milk-fed mice in the absence or presence of die-
tary pABA. The duration of liver stage development was indepen-
dent ofADCSandpABA, asdeterminedby the timeof blood stage
patency (Figure 4G). However, quantification of first-generation
Figure 4. Plasmodium Life Cycle Progression Remains Unaltered in the Absence of ADCS
(A and B) Normally fedmicewere co-injectedwith equal numbers of mCherry-fluorescent BerredWT andGFP-fluorescent adcs blood stage parasites and fed to
Anopheles stephensi mosquitoes. + and , presence or absence of pABA in the mosquito feeding solution.
(A) Quantification of oocysts and sporozoites. Shown is the mean percentage of all single-fluorescent parasites ± SDs. Parasites displaying dual mCherry and
GFP fluorescence as a result of cross-fertilization were excluded from analysis. n.s., non-significant; WT versus adcs, paired t test; + versus, Student’s t test;
n = 3.
(B) Infected mosquito midguts 10 days after the blood meal. Shown is a merge of mCherry (WT, red), GFP (adcs, green), and differential interference contrast
images (DIC). Bar, 100 mm.
(C–E) Normal oocyst maturation in the absence of ADCS and pABA. Parasites were transmitted from milk-fed mice to restrict pABA carryover during the blood
meal.
(C) Oocyst size on day 11 after the bloodmeal. Lines, mean values. n.s., non-significant; one-way ANOVA, Tukey’s multiple comparison test; n = 50 oocysts from
5 mosquitoes.
(D) Morphology of 11-day-old oocysts. Shown is a merge, as described above. Bar, 10 mm.
(E) Oocyst sporulation on day 14. Mean values ± SDs are shown. n.s., non-significant; one-way ANOVA, Tukey’s multiple comparison test; n = 10 infected
midguts.
(F) Quantification of liver stage parasites in vitro. Hepatoma cells were co-infected with WT and adcs sporozoites and imaged 24, 48, and 65 hr after infection. +
and, presence or absence of pABA in the culture medium. Shown is the mean percentage of all parasites ± SDs. n.s., non-significant; WT versus adcs, paired
t test; + versus , Student’s t test; n = 3. See also Figure S4.
(G) Time to development of patent blood infection. Milk-fedmicewere injected with equal numbers ofWT and adcs sporozoites. Peripheral bloodwasmonitored
daily by flow cytometry. n.s., non-significant; Mantel-Cox test; n = 7 mice from 3 independent experiments.
(H and I) Beneficial effect of dietary pABA on the first obligate parasite expansion phase in the liver. + and, presence or absence of pABA in the mouse drinking
water.
(legend continued on next page)
Cell Reports 26, 356–363, January 8, 2019 361
blood stage parasitemia and of parasite transcript abundance in
infected livers suggests a 3- to 5-fold fitness cost in the absence
of pABA, which is indicative of a growth-stimulatory function dur-
ing liver stage development in vivo. The lack of ADCS expression
causednosignificant defectsduring this stage (Figures4Hand4I).
Since the liver is a major folate pool (Lin et al., 2004), we
hypothesize that liver stage survival may be due to the salvage
of preformed folates in the absence of ADCS. Optimized folate
concentrations in the culture medium may thus account for
the discrepancies in pABA dependency observed in vitro and
in vivo.
It remains to be determined whether the pABA requirements of
human malaria pathogens during intrahepatic growth are com-
parable to those ofP. berghei, especially due to their significantly
longer development times in the liver. If confirmed by experi-
mental data, then differential requirements of folate building
blocks in different host tissues may signify opportunities for
stage-specific antimalarial intervention strategies.
Our results reveal critical roles of Plasmodium ADCS and
ADCL in endogenous folate synthesis during food-mediated
pABA scarcity in the mammalian host, but facultative pABA
auxotrophy is restricted to blood infection. Thus, by using two
complementary pathways, pABA salvage and endogenous
biosynthesis, Plasmodium elegantly solves its metabolic
dependence on this central folate precursor. We conclude
that the uptake of pABA and its derivatives, and not of folate,
promotes blood stage growth in vivo. Since pABA is metaboli-
cally irrelevant to mammals, its salvage may serve to prevent
folate competition between the malaria parasite and its host,
thereby significantly contributing to their shared biological
fitness.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Alexa Fluor 488-coupled goat anti-mouse IgG Thermo Fisher Scientific Cat# A11029; RRID: AB_2534088
Biological Samples
NMRI mouse sera from long term adcs– infections (9x) This study N/A
NMRI mouse serum from short term WT infection (1x) This study N/A
NMRI mouse serum from naive animal (1x) This study N/A
Chemicals, Peptides, and Recombinant Proteins
para-aminobenzoic acid (pABA) Sigma-Aldrich Cat# A9878
para-aminohippuric acid (pAHA) Sigma-Aldrich Cat# A1422
para-acetamidobenzoic acid (pACBA) Sigma-Aldrich Cat# 133337
para-aminobenzoylglutamic acid (pABG) Sigma-Aldrich Cat# PHR1334
5-methyltetrahydrofolic acid (5-MTHF), disodium salt Sigma-Aldrich Cat# M0132
Folic acid (FA) Sigma-Aldrich Cat# F7876
Pyrimethamine MP Biomedicals Cat# 0219418025
5-Fluorocytosine Sigma-Aldrich Cat# F7129
TRIzol Reagent Thermo Fisher Scientific Cat# 15596018
Critical Commercial Assays
Human T Cell NucleofectorTM Kit Lonza Cat# VPA-1002
PCR DIG Probe Synthesis Kit Roche Cat# 11636090910
DIG Luminescent Detection Kit Roche Cat# 11363514910
RETROscript Kit Thermo Fisher Scientific Cat# AM1710
Power SYBR Green PCR Master Mix Thermo Fisher Scientific Cat# 4368577
Experimental Models: Cell Lines
Homo sapiens (male) hepatoma cell line HuH-7 Nakabayashi et al., 1982; originally obtained
from Prof. Dr. Ralf Bartenschlager, Heidelberg
University Hospital, Heidelberg, D
HuH-7
Experimental Models: Organisms/Strains
Plasmodium berghei strain ANKA Janse et al., 2006; originally obtained from
Dr. Chris J. Janse, LUMC, Leiden, NL
Reference clone 15cy1
Plasmodium berghei strain Bergreen Kooij et al., 2012; generated in own lab N/A
Plasmodium berghei strain Berred Matz et al., 2013; generated in own lab N/A
Plasmodium berghei strain adcs–res. This study N/A
Plasmodium berghei strain adcs–sens. This study N/A
Plasmodium berghei strain adcl– This study N/A
Plasmodium berghei strain adcs-tag This study N/A
Plasmodium berghei strain adcl-tag This study N/A
Mus musculus strain Crl:NMRI(Han) Charles River Strain Code 605
Mus musculus strain C57BL/6NCrl Charles River Strain Code 027
Anopheles stephensi strain Sind-Kasur Feldmann and Ponnudurai, 1989; originally
obtained from Prof. Dr. Robert Sauerwein,




See Table S1 N/A N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
pBAT vector Kooij et al., 2012; generated in own lab N/A
ADCS knockout plasmid This study N/A
ADCL knockout plasmid PlasmoGEM PbGEM-539091
ADCS tagging plasmid This study N/A
ADCL tagging plasmid This study N/A
Software and Algorithms
GraphPad Prism GraphPad Software Version 5.03
FIJI Schindelin et al., 2012; Schneider et al.,
2012.
Versions continuously updated
XcaliburTM Thermo Fisher Scientific Version 4.1.31.9
Other
Fortified rodent diet Ssniff Cat# V1534-300
Whole milk powder (26% fat) Saliter N/A
Fetal Bovine Serum, dialyzed, US origin, One Shot Thermo Fisher Scientific Cat# A3382001
NucleofectorTM 2b Device Lonza Cat# AAB-1001
StepOnePlusTM Real-Time PCR System Thermo Fisher Scientific Cat# 4376600
Acquity UPLC I-Class System Waters N/A
Acquity UPLC HSS T3 VanGuard Pre-column, 100A˚,
1.8 mm, 2.1 mm X 5 mm,
Waters Cat# 186003976
Acquity UPLC HSS T3 Column, 100A˚, 1.8 mm,
2.1 mm X 100 mm
Waters Cat# 186003539
Exactive Orbitrap Mass Spectrometer Thermo Fisher Scientific Cat# IQLAAEGAAPFALGMBCACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Joachim
Michael Matz (joachim.michael.matz@hu-berlin.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
This studywas carried out in strict accordancewith theGerman ‘Tierschutzgesetz in der Fassung vom22. Juli 2009’ and theDirective
2010/63/EU of the European Parliament and Council ‘On the protection of animals used for scientific purposes’. The protocol was
approved by the ethics committee of the Berlin state authority (‘Landesamt f€ur Gesundheit und Soziales Berlin’, permit number
G0294/15).
C57BL/6NCrl mice were used for sporozoite infections. All other parasite infections were conducted with Crl:NMRI(Han) mice.
Experimental groups consisted of 8-12 weeks old female litter mates, which were housed together in groups of 3 to 6 animals in filter
top cages (Tecniplast, Buguggiate, Italy). The cages were bedded with aspen wood chips (LTE E-002, Abedd, Vienna, Austria) and
enriched with plastic tunnels (Ehret, Emmendingen, Germany). Mice were kept at room temperature under a 12 h light / 12 h dark
cycle at a constant relative humidity of 45%. For information regarding mouse diet, see Method Details.
Mosquitoes
A. stephensi larvae were reared in water containing 0.1% NaCl and were fed with dry cat food pellets (Brekkies, Affinity Petcare S.A,
Barcelona, Spain). 200-400 pupae were collected permosquito cage. Infectedmice were fed to the adult mosquitoes 7-10 days after
hatching. For information regarding mosquito feeding solutions, see Method Details.
Parasites
All parasite strains used in this study are derived from transfection of P. berghei ANKA cl15cy1. For more information on parasite
infections, see Method Details.Cell Reports 26, 356–363.e1–e4, January 8, 2019 e2
METHOD DETAILS
Transfection Constructs
Constructs for endogenous tagging of ADCS and ADCL with mCherry-3xMyc were designed for single homologous integration
(Figure S1A). The sequences directly upstream of the stop codons were amplified from genomic DNA (1,053 and 1,663 bp, respec-
tively) and inserted into the pBAT vector (Kooij et al., 2012) using HpaI in combination with EcoRI or NgoMIV. For the generation of the
ADCS deletion construct, the 30 fragment of the gene was amplified from genomic DNA (1,185 bp) and cloned into the pBAT vector
using the XhoI and KpnI restriction sites. Subsequently, the 50 fragment (508 bp) was amplified and cloned into the intermediate vec-
tors using SacII in combination with HpaI. Prior to transfection, the ADCS knockout vector was linearized with SalI. Deletion of ADCL
was performed with the respective NotI-digested PlasmoGEM vector (Schwach et al., 2015). Internal restriction sites were used for
linearization of the tagging vectors.
Recombinant Parasite Lines
We used advanced experimental genetic techniques to generate all recombinant parasite lines (Matz and Kooij, 2015). Purified WT
schizonts were transfected with 5 mg DNA using the NucleofectorTM 2b Device and the Human T Cell NucleofectorTM Kit (Lonza,
Basel, Switzerland; Janse et al., 2006). Transfected parasites were injected intravenously into naive NMRI mice, and selected in vivo
with pyrimethamine-containing drinking water (70 mg/l; MP Biomedicals, Santa Ana, CA, USA). Isogenic ADCS knockout mutants
were isolated by fluorescence-activated cell sorting (Kenthirapalan et al., 2012). ADCL-deficient parasites were cloned by limiting
dilution.
To validate correct integration of the transfection vectors and absence of remaining WT parasites, primer combinations were used
as indicated in Figures S1A and S1C and Table S1. Southern blot analysis using the PCR DIG Probe Synthesis kit and the DIG
Luminescent Detection kit (Roche, Rotkreuz, Switzerland) was performed according to the manufacturer’s instructions to confirm
the correct genotype of the adcs– parasite line. The probe was amplified with primers that were used to generate the 50 integration
sequence of the ADCS deletion construct (see Table S1) and hybridized to XmnI restriction-digested genomic DNA.
The adcs– parasites were also subjected to in vivo negative selection with 5-Fluorocytosine-containing drinking water (1 g/l; Sigma-
Aldrich, St. Louis, MO, USA) and to subsequent cloning by limiting dilution. Loss of the drug-selectable cassette was confirmed by
diagnostic PCR using the primer combinations indicated in Figure S2C.
Live Cell Imaging
In order to assess protein expression, transgenic parasites expressing mCherry-3xMyc-tagged proteins were passed through the
parasite life cycle and imaged live. Fluorescence imaging was performed with a Zeiss AxioObserver Z1 epifluorescence microscope
equipped with a Zeiss AxioCam MRm camera (Zeiss, Oberkochen, Germany).
For the detection of anti-parasitic antibodies, 0.5 to 1mL of blood was collected by cardiac puncture and cellular components and
serum were separated by centrifugation. Sera of adcs–-infected mice were pooled. Immunofluorescence analysis was performed at
room temperature by incubating live Berred WT-infected erythrocytes in 100% mouse serum containing 1:500 Alexa Fluor
488-coupled goat anti-mouse IgG (Life Technologies, Carlsbad, CA, USA) for one hour.
During quantitative assessment of ADCS expression, the GFP-fluorescent Bergreen WT reference strain was used as a negative
control (Kooij et al., 2012). Microscope settings and exposure times were kept constant to ensure comparability. Signal intensities
and parasite sizes were analyzed using FIJI with the appropriate plugins (Schindelin et al., 2012; Schneider et al., 2012).
Metabolite Restriction and Supplementation
Mice were fed ad libitum with conventional fortified rodent diet (V1534-300, ssniff, Soest, Germany), or with a diet based on spray-
dried wholemilk powder (Saliter, Obergr€unzburg, Germany). Milk powder wasmixedwith water, formed into pellets and dried at 60 to
80C. Mice readily accepted the diet. For phenotypic rescue experiments, drinking water was supplemented with 20 mg/l pABA
(Sigma-Aldrich) or equimolar concentrations of 5-MTHF (Sigma-Aldrich). Due to low water solubility, 1.3 mg/kg or 10 mg/kg FA
(Sigma-Aldrich) was added to the milk powder. The concentration of 1.3 mg/kg is in the range of the FA levels used in the United
States food fortification program (Crider et al., 2011) and exceeds the endogenous 5-MTHF levels of the milk diet by eight times
(Figure 2B).
For growth analysis, mice were given different diets, starting two days before parasite injection. For metabolite quantification of
mouse sera, naive animals were given different diets for seven days.
Throughout mosquito infection, the feeding solution contained 10% sucrose and either none or 0.05% pABA. During liver stage
analysis, cells were grown in Dulbecco’s Modified Eagle Medium (DMEM), containing 10% dialyzed fetal bovine serum (Thermo
Fisher Scientific, Waltham, USA) with or without 5 mg/l pABA.
Metabolite Quantification
Mouse sera, supplemented drinking water, and diet were stored at 80C prior to metabolite extraction. 200 ml of frozen mouse
serum were homogenized in 800 ml of 100% methanol by using a mixer mill with a zirconia bead for 1 minute at 20 Hz. The extract
was sonicated for 10 minutes at 4C. Afterward, the sample was centrifuged at 20,000 g for 10 minutes at 4C. Supernatants weree3 Cell Reports 26, 356–363.e1–e4, January 8, 2019
dried overnight in a speed vacuum concentrator. The dried sample was dissolved in 150 ml of 80% methanol followed by centrifu-
gation as described above.
35mg of groundmilk pellets and conventional mouse diet were homogenized in 350 ml of 80%methanol followed by centrifugation
and extraction as above. Food and serum extracts were spiked with 5 mg/ml isovitexin. Drinking water samples were centrifuged and
processed as above.
UPLC/Orbitrap-MS analysis for folate-related metabolites was performed as described previously (Giavalisco et al., 2011). For
UPLC separation, 5 ml of the sample were injected into an Acquity UPLC I-Class system equipped with an HSS T3 VanGuard pre-
column and an HSS T3 column (Waters, Milford, MA, USA; see also Key Resources Table). Mobile phases were 0.1% formic acid
in water and 0.1% formic acid in acetonitrile. Mass spectra were acquired using an ExactiveTM Orbitrap mass spectrometer (Thermo
Fisher Scientific). pABA, pAHA, pACBA, pABG, 5-MTHF and FA were identified and quantified by high resolutionm/z detection using
data obtained by co-elution profile of the respective standard compounds (Sigma Aldrich). Data were analyzed using Xcalibur
(version 4.1.31.9, Thermo Fisher Scientific).
Blood Stage Development
Blood stage development was assessed using the previously described intravital competition assay (Matz et al., 2013). In short, 500
mCherry-fluorescent Berred WT and 500 GFP-fluorescent adcs– blood stage parasites were co-injected intravenously into NMRI
mice. For single infections with WT, adcs– or adcl–, 1,000 blood stage parasites were injected. Parasitemia was analyzed daily by
flow cytometry or by microscopic analysis of Giemsa-stained thin blood films.
Mosquito Infections
To test parasite performance during mosquito infection normally fed NMRI mice were co-injected intravenously with 5x106 Berred
WT and 5x106 adcs– blood stage parasites and fed toA. stephensimosquitoes three days later. Prior to feeding parasitemias of donor
miceweremeasured using flow cytometry. Oocysts and sporozoites were visualized and quantified by live fluorescencemicroscopy.
In order to restrict the carry-over of pABA-relatedmetabolites from the bloodmeal, 107 BerredWT or 107 adcs– blood stage parasites
were injected individually into milk-fed animals. For sporozoite production and subsequent liver stage analysis Berred WT and adcs–
parasites were also transmitted individually.
Liver Stage Analysis
Analysis of liver stage development in vitro was performed with human hepatoma cells (HuH-7, not independently authenticated)
which were seeded onto m-slide 8 well glass bottom slides (Ibidi, Munich, Germany) and inoculated with a mixed population of
5,000 Berred WT and 5,000 adcs– sporozoites at subconfluence. Infected cells were grown at a temperature of 37C and a CO2 con-
centration of 5%. Liver stages were imaged and quantified live 24, 48 and 65 hours after infection.
To assess liver stage development in vivoC57BL/6 mice were injected intravenously with 104 BerredWT or 104 adcs– sporozoites.
For the measurement of first generation parasitemia peripheral blood was subjected to flow cytometry three days after infection. For
the quantification of parasite loads livers were harvested 42 hours after injection and total RNA was extracted using TRIzol
reagent (Thermo Fisher Scientific). cDNA was synthesized from 1 mg of total RNA with the RETROscript kit (Thermo Fisher Scientific)
and quantitative PCR was performed with StepOnePlus (Thermo Fisher Scientific) using Power SYBR Green PCR Master
Mix (Thermo Fisher Scientific). The assay was performed in triplicate using primers against mouse GAPDH and parasite 18S
rRNA (Table S1; Friesen et al., 2010).
QUANTIFICATION AND STATISTICAL ANALYSIS
Growth curves were analyzed with an ANCOVA. Values > 1% were excluded to restrict analysis to the exponential growth phase.
During competitive life cycle progression mutant and WT were compared with a paired t test, comparisons between supplemented
and non-supplemented conditions were analyzed with a Student’s t test. For comparison of multiple independent experimental con-
ditions, a one-way ANOVA was used in combination with Tukey’s multiple comparison test. Time to blood stage patency was
analyzed with a Mantel-Cox test. All statistical testing was performed with Prism (version 5.03, GraphPad Software, La Jolla, CA,
USA). Effects with P values smaller than 0.05 were considered significant. Statistical details can be found in the corresponding
Figure legends.Cell Reports 26, 356–363.e1–e4, January 8, 2019 e4
